Literature DB >> 4357054

Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.

H R Thacore, J S Youngner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4357054     DOI: 10.1016/0042-6822(73)90054-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  7 in total

1.  Abortive infection of a rabbit cornea cell line by vesicular stomatitis virus: conversion to productive infection by superinfection with vaccinia virus.

Authors:  H R Thacore; J S Youngner
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

2.  Rescue of vesicular stomatitis virus from homologous and heterologous interferon-induced resistance in human cell cultures by poxviruses.

Authors:  H R Thacore
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

3.  Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA.

Authors:  R F Pacha; R C Condit
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

4.  Adenovirus early region 1A modulation of interferon antiviral activity.

Authors:  K P Anderson; E H Fennie
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.

Authors:  A P Rice; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Collateral Lethal Effects of Complementary Oncolytic Viruses.

Authors:  Justin W Maroun; Velia Penza; Taylor M Weiskittel; Autumn J Schulze; Stephen J Russell
Journal:  Mol Ther Oncolytics       Date:  2020-06-24       Impact factor: 7.200

7.  Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.

Authors:  María M Lorenzo; Juana M Sanchez-Puig; Rafael Blasco
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.